Related Experiment Video
Updated: Feb 4, 2026

Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Published on: July 5, 2019
Improvements of an oral anti-cancer drug safety management program for patients with cancer
Hong Yang1, Hong Zhang1, Jingjuan Zhou1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Nursing Department, Peking University Cancer Hospital & Institute, Beijing, China.
Objective:
To evaluate the impact of an oral anti - cancer drug safety management program on nurses and patients.
Methods:
This study was a hospital-level quality-improvement evaluation (pre-post, quasi-experimental design) and was not registered as a clinical trial. It was conducted from August 2024 to December 2024 in a tertiary hospital in Beijing. The program comprised three stages: preparation, training, implementation and supervision. It included tiered training for nurses based on established nursing standards, standardized health education checklists for patients, and continuous support through virtual and in-person clinic visit. Associated improvements were evaluated using self-designed questionnaires. Data were collected from nurses before training and 2 months after program implementation, and from patients before and 1 month after education. Descriptive statistics and non-parametric paired sample tests were used for analysis.
Results:
A total of 632 nurses participated in the program, of which 381 nurses completed both evaluations. The knowledge and behavior scores of nurses regarding on correct medication administration, protection against drug exposure, and early management of adverse reactions improved significantly (P < 0.001). The full-score rates for knowledge and behavior increased from 71.82% and 71.55% to92.65% and 94.49%, respectively (Z = -11.462, -13.104, respectively; both P < 0.001). A total of 643 patients received guidance, of which 384 patients completed both evaluations. The knowledge and behavior scores of patients also improved significantly (P < 0.001), with the full-score rates increasing from 59.46% and 68.29% to78.62% and 85.11%, respectively (Z = -11.473, -12.415, respectively; both P < 0.001).
Conclusions:
Meaningful improvements were achieved through enhancements to the oral anti-cancer drug safety management program. Standardized training and structured implementation enabled nurses to provide evidence-based patient guidance, thereby enhancing patients' knowledge and skills in safe medication management.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

